Unexpected systemic sclerosis in a patient with atopic dermatitis receiving dupilumab: a novel case report
{{output}}
Dupilumab, an interleukin (IL)-4 receptor alpha antagonist, is widely used in the treatment of atopic dermatitis and has shown potential benefit in certain fibrosing skin conditions. While blockade of IL-4 and IL-13 is generally considered to inhibit fibrosis,... ...
